Invitrox offers a full suite of FDA approved tests to determine the immune response to human immunodeficiency virus (HIV) including confirmatory testing for HIV antibodies to ensure the accuracy of the serologic status for this virus.
We offer two separate tests:
Avioq HIV-1 Microelisa System is an enzyme-linked immunosorbent assay (ELISA) for the qualitative detection of antibodies to HIV-1 (a leading causal agent of AIDS in the U.S.) in human specimens collected as serum, plasma, dried blood spots, or oral fluid specimens obtained with the OraSure® HIV-1 Oral Specimen Collection Device.
For more information click here. (Avioq HIV-1 Microelisa System)
The VioOne™ HIV Profile™ Supplemental Assay is an enzyme-linked immunosorbent assay (ELISA) for confirmation and differentiation of individual antibodies directed to various gene products of HIV-1 (Group M & Group O) and HIV-2 in human serum or plasma. It is a more specific test used to
confirm the presence of HIV-1 and/or HIV-2 antibodies from specimens that
were repeatedly reactive in diagnostic screening procedures.
For more information click here. (HIV Supplemental Assay (avioq.com)